Clinical Trial Access in Diverse Populations

Area of Science:

• Oncology
• Health Equity
• Clinical Research

Background:

• Cancer disproportionately affects minority populations.
• Participation of minority groups in oncologic clinical trials is significantly low.
• Key contributing factors include historical mistrust, systemic barriers, and implicit bias within the medical system.

Purpose of the Study:

• To identify and address the underrepresentation of minority groups in cancer clinical trials.
• To explore strategies for enhancing access and diversity in oncology research.
• To promote equitable healthcare delivery and improve research outcomes for all populations.

Main Methods:

• Review of existing literature on barriers to clinical trial participation.
• Analysis of current strategies aimed at improving minority enrollment.
• Identification of best practices for inclusive clinical trial design and implementation.

Main Results:

• Mistrust, structural impediments, and implicit bias are primary reasons for low minority participation.
• Pragmatic trial designs can increase accessibility.
• Patient navigation, financial assistance, and diverse healthcare professionals are effective interventions.

Conclusions:

• Addressing disparities in cancer clinical trial participation is essential for health equity.
• Implementing targeted strategies can significantly improve representation of minority groups.
• Enhancing diversity in clinical research leads to better health outcomes for underrepresented populations.